This is a Phase 1 study to evaluate the pharmacokinetics (PK), safety and tolerability of
epetraborole tablets in adult subjects with normal renal function, subjects with various
degrees of renal impairment, and subjects with end-stage renal disease (ESRD) receiving
intermittent hemodialysis (IHD) therapy.